CDKN1B and glioma: Activation of PI3K/Akt leads to upregulation of cell-cycle regulator Cyclin D1 and downregulation of p27Kip1, resulting in the promotion of glioma proliferation, cell cycle progression and a significant increase in the percentage of S-phase cell.